How well does Mounjaro(Tirzepatide) work?

MOUNJARO (tirzepatide) is a dual GIP/GLP-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, demonstrating significant HbA1c reduction across various clinical scenarios.

Pharmacotherapeutic Efficacy of Tirzepatide in Glycemic Management

Tirzepatide functions as a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. This unique dual receptor activity distinguishes it from pure GLP-1 receptor agonists, providing enhanced glycemic control through complementary pathways. The medication works primarily by stimulating insulin secretion and suppressing glucagon in a glucose-dependent manner.